Modifiable influences on female HPV vaccine uptake at the clinic encounter level: A literature review
dc.contributor.author | Small, Stephanie L. | en_US |
dc.contributor.author | Sampselle, Carolyn M. | en_US |
dc.contributor.author | Martyn, Kristy K. | en_US |
dc.contributor.author | Dempsey, Amanda F. | en_US |
dc.date.accessioned | 2014-09-03T16:52:10Z | |
dc.date.available | WITHHELD_13_MONTHS | en_US |
dc.date.available | 2014-09-03T16:52:10Z | |
dc.date.issued | 2014-09 | en_US |
dc.identifier.citation | Small, Stephanie L.; Sampselle, Carolyn M.; Martyn, Kristy K.; Dempsey, Amanda F. (2014). "Modifiable influences on female HPV vaccine uptake at the clinic encounter level: A literature review." Journal of the American Association of Nurse Practitioners 26(9): 519-525. | en_US |
dc.identifier.issn | 2327-6886 | en_US |
dc.identifier.issn | 2327-6924 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/108355 | |
dc.description.abstract | Purpose A review of the literature to identify modifiable influences on female human papillomavirus (HPV) vaccine uptake relevant to clinical practice in order to support nurse practitioners (NPs) in the prevention of cervical cancer. Data sources PubMed, CINAHL, reference lists of publications that surfaced in the electronic search. Conclusions Six influences are modifiable and potentially amenable to being addressed at the clinic encounter level: (a) cost and insurance coverage, (b) provider recommendation, (c) vaccination opportunity, (d) HPV and HPV vaccine knowledge, (e) vaccine safety concerns, and (f) HPV risk. Implications for practice NPs have an important role in improving HPV vaccine uptake and research suggests several areas they can address to increase vaccination during clinic visits. | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Immunization | en_US |
dc.subject.other | Human Papilloma Virus (HPV) | en_US |
dc.subject.other | Vaccination | en_US |
dc.subject.other | Prevention | en_US |
dc.title | Modifiable influences on female HPV vaccine uptake at the clinic encounter level: A literature review | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Nursing | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/108355/1/jaan12057.pdf | |
dc.identifier.doi | 10.1002/2327-6924.12057 | en_US |
dc.identifier.source | Journal of the American Association of Nurse Practitioners | en_US |
dc.identifier.citedreference | Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. ( 2009 ). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, national immunization survey‐adult 2007. Preventive Medicine, 48 ( 5 ), 426 – 431. doi: 10.1016/j.ypmed.2008.11.010 | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. ( 2011 ). National and state vaccination coverage among adolescents aged 13 through 17 years—United States, 2010. Morbidity and Mortality Weekly Report, 60 ( 33 ), 1117 – 1123. | en_US |
dc.identifier.citedreference | Chao, C., Velicer, C., Slezak, J. M., & Jacobsen, S. J. ( 2010 ). Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171 ( 3 ), 357 – 367. doi: 10.1093/aje/kwp365 | en_US |
dc.identifier.citedreference | Conroy, K., Rosenthal, S. L., Zimet, G. D., Jin, Y., Bernstein, D. I., Glynn, S., & Kahn, J. A. ( 2009 ). Human papillomavirus vaccine uptake, predictors of vaccination, and self‐reported barriers to vaccination. Journal of Women's Health, 18 ( 10 ), 1679 – 1686. doi: 10.1089/jwh.2008.1329 | en_US |
dc.identifier.citedreference | Cook, R. L., Zhang, J., Mullins, J., Kauf, T., Brumback, B., Steingraber, H., & Mallison, C. ( 2010 ). Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. Journal of Adolescent Health, 47 ( 6 ), 596 – 599. doi: 10.1016/j.jadohealth.2010.09.015 | en_US |
dc.identifier.citedreference | Dempsey, A. F., Abraham, L. M., Dalton, V., & Ruffin, M. ( 2009 ). Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Annals of Epidemiology, 19 ( 8 ), 531 – 538. doi: 10.1016/j.annepidem.2009.03.011 | en_US |
dc.identifier.citedreference | Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. ( 2010 ). Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university‐based health system. Vaccine, 28 ( 4 ), 989 – 995. doi: 10.1016/j.vaccine.2009.10.133 | en_US |
dc.identifier.citedreference | Dunne, E. F., Unger, E. R., Sternberg, M., McQuillan, G., Swan, D. C., Patel, S. S., & Markowitz, L. E. ( 2007 ). Prevalence of HPV infection among females in the United States. Journal of the American Medical Association, 297 ( 8 ), 813 – 819. doi: 10.1001/jama.297.8.813 | en_US |
dc.identifier.citedreference | Gerend, M. A., Weibley, E., & Bland, H. ( 2009 ). Parental response to human papillomavirus vaccine availability: Uptake and intentions. Journal of Adolescent Health, 45 ( 5 ), 528 – 531. doi: 10.1016/j.jadohealth.2009.02.006 | en_US |
dc.identifier.citedreference | Gottlieb, S. L., Brewer, N. T., Sternberg, M. R., Smith, J. S., Ziarnowski, K., Liddon, N., & Markowitz, L. E. ( 2009 ). Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. Journal of Adolescent Health, 45 ( 5 ), 430 – 437. doi: 10.1016/j.jadohealth.2009.03.029 | en_US |
dc.identifier.citedreference | Guerry, S. L., De Rosa, C. J., Markowitz, L. E., Walker, S., Liddon, N., Kerndt, P. R., & Gottlieb, S. L. ( 2011 ). Human papillomavirus vaccine initiation among adolescent girls in high‐risk communities. Vaccine, 29, 2235 – 2241. doi: 10.1016/j.vaccine.2011.01.052 | en_US |
dc.identifier.citedreference | Insinga, R. P., Dasbach, E. J., & Elbasha, E. H. ( 2005 ). Assessing the annual economic burden of preventing and treating anogenital human papillomavirus‐related disease in the US: Analytic framework and review of the literature. Pharmacoeconomics, 23 ( 11 ), 1107 – 1122. | en_US |
dc.identifier.citedreference | Licht, A. S., Murphy, J. M., Hyland, A. J., Fix, B. V., Hawk, L. W., & Mahoney, M. C. ( 2010 ). Is use of the HPV vaccine among female college students related to HPV knowledge and risk perception? Sexually Transmitted Infections, 86 ( 1 ), 74 – 78. doi: 10.1136/sti.2009.037705 | en_US |
dc.identifier.citedreference | Mathur, M., Mathur, V., & Reichling, D. ( 2010 ). Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. Journal of Pediatric Health Care, 24 ( 1 ), 14 – 24. doi: 10.1016/j.pedhc.2008.11.004 | en_US |
dc.identifier.citedreference | Moore, G. R., Crosby, R. A., Young, A., & Charnigo, R. ( 2010 ). Low rates of free human papillomavirus vaccine uptake among young women. Sexual Health, 7 ( 3 ), 287 ‐ 290. doi: 10.1071/SH09136 | en_US |
dc.identifier.citedreference | Rand, C. M., Shone, L. P., Albertin, C., Auinger, P., Klein, J. D., & Szilagyi, P. G. ( 2007 ). National health care visit patterns of adolescents. Archives of Pediatric and Adolescent Medicine, 161 ( 3 ), 252 – 259. doi: 10.1001/archpedi.161.3.252 | en_US |
dc.identifier.citedreference | Reiter, P. L., Cates, J. R., McRee, A. L., Gottlieb, S. L., Shafer, A., Smith, J. S., & Brewer, M. T. ( 2010 ). Statewide HPV vaccine initiation among adolescent females in North Carolina. Sexually Transmitted Diseases, 37 ( 12 ), 549 – 556. doi: 10.1097/OLQ.0b013e3181d73bf8 | en_US |
dc.identifier.citedreference | Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. ( 2011 ). Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation. Vaccine, 29 ( 5 ), 890 – 895. doi: 10.1016/j.vaccine.2009.12.063 | en_US |
dc.identifier.citedreference | Schluterman, N. H., Terplan, M., Lydecker, A. D., & Tracy, J. K. ( 2011 ). Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine, 29, 3767 – 3772. doi: 10.1016/j.vaccine.2011.03.032 | en_US |
dc.identifier.citedreference | Slade, B. A., Leidel, L., Vellozzi, C., Woo, E. J., Hua, W., Sutherland, A., Izurieta, H. S., Ball, R., Miller, N., Braun, M. M., Markowitz, L. E., & Iskander, J. ( 2009 ). Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA, 302 ( 7 ), 750 – 759. | en_US |
dc.identifier.citedreference | Small, S. L., & Patel, D. A. ( 2012 ). Impact of HPV vaccine availability on uptake. Journal for Nurse Practitioners, 8 ( 1 ), 61 – 66. | en_US |
dc.identifier.citedreference | Zimet, G. D., Weiss, T. W., Rosenthal, S. L., Good, M. B., & Vichnin, M. D. ( 2010 ). Reasons for non‐vaccination against HPV and future vaccination intentions among 19–26 year‐old women. BMC Women's Health, 10 ( 27 ), 1 – 6. | en_US |
dc.identifier.citedreference | Bosch, F. X., Lorincz, A., Muñoz, M., Meijer, C. J., & Shah, K. V. ( 2002 ). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55 ( 4 ), 244 – 265. | en_US |
dc.identifier.citedreference | Brewer, N. T., & Fazekas, K. I. ( 2007 ). Predictors of HPV vaccine acceptability: A theory‐informed, systematic review. Preventive Medicine, 45, 107 – 114. doi: 10.1016/j.ypmed.2007.05.013 | en_US |
dc.identifier.citedreference | Brewer, N. T., Gottlieb, S. L., Reiter, P. L., McRee, A., Liddon, N., Markowitz, L., & Smith, J. S. ( 2011 ). Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high‐risk geographic area. Sexually Transmitted Diseases, 38 ( 3 ), 197 – 204. doi: 10.1097/OLQ.0b013e3181f12dbf | en_US |
dc.identifier.citedreference | Caskey, R., Lindau, S. T., & Alexander, G. C. ( 2009 ). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45 ( 5 ), 453 – 462. doi: 10.1016/j.jadohealth.2009.04.021 | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. ( 2007 ). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report, 56 ( RR‐2 ), 1 – 24. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. ( 2010 ). Adult vaccination coverage reported via NHIS. Retrieved from www.cdc.gov/vaccines/stats‐surv/nhis/default.htm | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.